Navidea Biopharmaceuticals

About:

Navidea develops precision immunodiagnostic agents and immunotherapeutics for patients with cancer, autoimmune, and infectious diseases.

Website: https://www.navidea.com

Twitter/X: navideabio

Top Investors: CRG, Oxford Finance LLC, Crede CapitalGroup, John K. Scott

Description:

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) focuses on the development of innovative immunodiagnostic agents and immunotherapeutics to enhance patient care by identifying the sites and pathways of disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. Patients and physicians, aspire to provide innovative immunodiagnostic agents and therapies to improve patient care for serious diseases. For investors, they aim to deliver superior growth through their focus on developing their innovative Manocept™ platform and driving efficient business processes. For their employees, they provide a culture that focuses on the direct contributions their efforts make for the patients they serve and an innovative development environment for new breakthrough products.